Doctors figure out a better way of assessing the severity of a man’s illness in order to give him the best possible treatment
NEW prostate cancer screening can give a more accurate estimate of a man’s risk of dying, Cambridge University scientists said.
As a result treatment can be individually tailored, which could range from surgery to management by regular observation, as well as providing advice and support.
Prostate cancer is one of the most common male cancers in the world, with nearly a million men diagnosed annually and the number of cases increasing
It is estimated the number of men diagnosed with the cancer will be around 70,000 a year in the UK by 2030, an increase of 69 per cent on current levels.
Over four fifths will have localised or locally advanced non-metastatic disease and they will be a bigger burden on the NHS in the years to come.
Honorary Consultant Urologist Dr Vincent Gnanapragasam said: “Risk estimation is the cornerstone of management for these men.
“Risk stratification is the primary method of deciding which treatment is appropriate for an individual.
“However, the current method of risk stratification is based on historical data and was not originally validated against prostate cancer mortality as an outcome.
“Moreover, no current risk stratification system has been developed first in an unscreened population, which represents the vast majority of men presenting with prostate cancer worldwide.
“Current risk models therefore require improvement to be more relevant for the management of prostate cancer in patients.
Source: The Sun
Urologists like Dr. Fredrick J. Snoy can provide treatment recommendations if you are experiencing symptoms of prostate cancer. Please contact our office for an appointment if you would like to discuss with Dr. Snoy, (505) 872-4091.